About this trial
The primary objective of this study is to demonstrate the non-inferiority of cCeLL compared to frozen section analysis. The investigational device is intended for use with indocyanine green (ICG) for fluorescence imaging as an aid in the visualization of vessels (micro- and macro-vasculature) blood flow in the cerebrovascular before, during or after cranial diagnostic and therapeutic procedures, such as tumor biopsy and resection, which is then read and analyzed by trained-professional for intraoperative diagnosis. The comparison will be held by the device with the conventional intraoperative histological frozen section analysis of identical brain tissue samples in the same patient. Both methods will be compared in terms of their accuracy using the standard of practice, the final pathological diagnosis.
Eligibility criteria
Qualifiers
Male or female patients aged 18 years or older
Patients suspected of having a brain tumor who are scheduled for neurosurgery and are considered candidates for tumor resection
Patients who understand and have signed the informed consent form
Specimens obtained from patients who have agreed to participate in this clinical trial and who meet the inclusion criteria
Disqualifiers
Patients undergoing multiple surgeries
Patients with bacterial or viral infections
Patients who develop allergic reactions to the investigational medical device
Patients with a history of allergy to Indocyanine Green (ICG)
Trial design
Treatments tested in this trial
- cCeLL In vivo
- Indocyanine Green